Nantong Tumor Hospital

Recent papers from Nantong Tumor Hospital

1. Prognostic and clinicopathological significance of circular RNA expression in cholangiocarcinoma: a systematic review and meta-analysisBMC Cancer · 2026
2. Modulation of anti-tuberculosis drug-induced liver injury by gut microbiota metabolites: Insights from network pharmacologyInternational Microbiology · 2026
3. Photothermal-Amplified Enzyme-Catalyzed Cascade Based on Gold Nanoparticle-Decorated MXene Overcoming H2O2 Barrier for Synergistic Tumor TherapyACS Applied Nano Materials · 2026
4. Projected country-level health effects and service requirements of Helicobacter pylori screen-and-treat and targeted endoscopic screening, 2025–2050: a comparative modelling studyInfectious Agents and Cancer · 2026
5. Development and reliability test of the work stress questionnaire for cancer survivors after returning to work (WSQ-CS)Scientific Reports · 2026
6. Targeting Microglial HDAC5 Suppresses NLRP3 Inflammation via NF ‐ κB Deacetylation to Alleviate Ischemic Brain InjuryCNS Neuroscience & Therapeutics · 2026
7. A Magnesium-Phenolic Coordinated Hydrogel Orchestrates Antiapoptotic, Immunomodulatory, and Angiogenic Niches for Aging Wound RegenerationACS Applied Materials & Interfaces · 2026
8. A palmitoylation-related signature predicts prognosis and immune microenvironment features in diffuse large B-cell lymphomaFrontiers in Immunology · 2026
9. MATR3 promotes proliferation and invasion of colon adenocarcinoma cells: bulk, single-cell transcriptomic analysis and experimental validationTranslational Oncology · 2026
10. Beyond local control: radiotherapy–immunotherapy combinations from in situ vaccination to systemic immune remodelingFrontiers in Genetics · 2026
11. Tumor-associated macrophages in gastric cancer peritoneal metastasis: orchestrating immune evasion, niche remodeling, and therapeutic resistanceFrontiers in Immunology · 2026
12. Interpretation and Implementation Prospects of the Expert Consensus on Clinical Application for Patient-controlled Analgesia Based on Intelligent Analgesia TechnologyInternational Journal of Pain Research · 2026
13. Paclitaxel oral solution versus paclitaxel injection as second-line therapy for advanced gastric cancer: a multicenter, open-label, randomized phase III trialESMO Open · 2026
14. Mefatinib versus gefitinib as a first-line treatment for EGFR-mutated non-small cell lung cancer: a randomized, double-blind, multicenter phase III studySignal Transduction and Targeted Therapy · 2026
15. Clinical utility of molecular residual disease detection in early-stage resected EGFR-mutated non-small cell lung cancerNature Communications · 2026
16. Fibrillarin Resists Cellular Senescence Via SIRT1‐Dependent Nicotinamide Metabolism and Its Inhibition Sensitizes Senolytic Therapy in Esophageal Squamous Cell CarcinomaAdvanced Science · 2026
17. RPS4Y1 in immune modulation and progression of prostate cancerDiscover Oncology · 2026
18. Spatial Heterogeneity, Temporal Evolution, and Matching Levels of Population Aging, Nurses, and Elderly Care Facilities in ChinaPublic Health Nursing · 2026
19. Identification of Hub Gene Characteristics and Immune Landscapes Across Aging Subtypes in Atherosclerosis: A Machine Learning‐Based Multi‐Omics Study With Experimental VerificationChemical Biology & Drug Design · 2026
20. Predictive value of triglyceride combined with age-adjusted D-dimer in patients with early-stage cervical cancerJournal of International Medical Research · 2026